Explore Emerging Opportunities in Business and Technology Tonight on Bloomberg

Wall Street is quiet on a Saturday evening. But if you tune your television to Bloomberg at 6:30 p.m. ET tonight, you will see the floor of the New York Stock Exchange. It is the backdrop for a program that aims to capture what the daily noise often misses. The show is called New to The Street. Its latest episode features four executives whose companies operate at the ragged edge of finance, medicine, media, and energy.

This is not typical financial news. There is no discussion of Fed policy or monthly jobs reports. The host, Jane King, speaks with founders and CEOs who are building things. They are trying to solve concrete problems. They want to connect capital to growth, treat debilitating diseases, reinvent television distribution, and literally reinvent power generation. Their stories are a snapshot of where speculative capital and human ambition are flowing right now.

Bilal Adam leads Stewards Investment Capital. His firm operates between developed and emerging markets, with a focus on Africa. He discusses private credit. This is the practice of lending money directly to companies outside of the traditional banking system. It is a major, growing asset class. Institutional investors like pension funds crave the yield it can offer. Adam’s firm seeks to channel that capital into projects that also build infrastructure, like telecommunications towers in underserved regions. He ties this activity to Stewards Inc., a Nasdaq-listed financial platform. The pitch is straightforward. They offer investors portfolio diversification and access to growth stories in markets many find opaque. The underlying promise is that finance can be both profitable and constructive.

In biotech, the story turns to long COVID. Cuong Do, the President and CEO of BioVie Inc., presents data from a clinical trial. He states that the company’s investigational drug, bezisterim, showed statistically significant improvement in patients suffering from severe fatigue and cognitive impairment. The data was presented at a professional neurology conference and published in a peer-reviewed journal. This is a critical point for credibility. Do calls it a first for impacting neurological symptoms of long COVID. All twelve independent advisors who reviewed the data reportedly urged the company to proceed to a larger Phase 3 trial. The next steps involve discussions with the U.S. Food and Drug Administration and an invitation to present at a National Institutes of Health forum. The gap between a promising Phase 2 result and a confirmed, approved treatment remains vast. But for a condition affecting millions with no approved therapies, even a signal of efficacy draws intense attention from both patients and investors.

William Mobley wants to talk about connections. His company, FreeCast, does not produce a streaming service you can subscribe to. Instead, it sells the software backbone that allows other companies to become media distributors. Think of your internet provider or wireless carrier. Mobley’s argument is that these companies already have a billing relationship with you. FreeCast gives them the technology to offer a branded hub of television, movies, sports, and shopping. The telecom brings the customer. FreeCast brings the content aggregation and monetization tools. Mobley introduces a metric called PEAC, for “partner-enabled addressable customers.” This number represents the total potential audience reach through all of FreeCast’s enterprise partnerships. He is careful to note this is not a count of active users or revenue. It is a measure of total market opportunity. The company’s commercial challenge is converting that potential into actual transactions across advertising, subscriptions, and commerce.

Then, the conversation makes its largest leap. Brent Nelson, Executive Chairman of American Fusion Inc., discusses the Texatron Fusion Engine. Fusion power has been a theoretical goal for generations, promising limitless clean energy. Nelson describes a practical machine. He says it uses a deuterium and helium-3 fuel cycle, producing helium-4 with no radioactive waste. The system uses pulsed magnetic confinement, powered by electricity rather than giant external magnets, and directly harvests electrons as electrical current. The stated applications range from powering data centers to remote industrial sites. “We think that we’re the first ones to crack that commercial nut,” Nelson said. The company trades on the OTCQB venture market. The distance between a promising design and a commercially viable, grid-ready fusion reactor is perhaps the longest of any frontier explored on the program. The claim itself is a testament to the enduring allure of the ultimate energy solution.

Watching these segments together creates a distinct impression. This is a landscape of pure potential. Each executive is selling a vision of a future that works differently. They are targeting investors who are comfortable with high risk for the possibility of transformative reward. The program itself, as sponsored programming, is a part of this ecosystem. It provides a platform for these stories to reach a global Bloomberg audience and millions more on YouTube.

The common thread is scale. Stewards looks at continental scale in emerging markets. BioVie targets a patient population numbering in the millions globally. FreeCast metrics talk about partner networks reaching countless households. American Fusion speaks to the entire global energy grid. The narratives are built for growth investors.

For you, the viewer or the investor, the calculus is familiar. You must separate operational progress from promotional ambition. You look for signposts of real traction:

• Peer-reviewed data and regulatory engagement for BioVie
• Translation of PEAC numbers into financial statements for FreeCast
• Performance of credit funds for Stewards
• Move from design to a working prototype for American Fusion
• Concrete problem-solving by each executive
• High-risk investment appeal for transformative reward

The stories are compelling. The future they paint is ambitious. Your job is to decide which foundations are being built with steel, and which are still being drawn on blueprints. Tonight’s show offers you four very different blueprints to consider.